Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.51 - $17.1 $63,067 - $2.11 Million
-123,662 Reduced 72.94%
45,881 $32,000
Q3 2022

Nov 09, 2022

BUY
$1.01 - $17.0 $115,746 - $1.95 Million
114,600 Added 208.58%
169,543 $258,000
Q2 2022

Aug 10, 2022

SELL
$0.54 - $1.41 $330,564 - $863,141
-612,157 Reduced 91.76%
54,943 $55,000
Q1 2022

May 13, 2022

SELL
$1.4 - $5.15 $10,080 - $37,080
-7,200 Reduced 1.07%
667,100 $961,000
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $866,327 - $1.41 Million
-202,887 Reduced 23.13%
674,300 $3.52 Million
Q3 2021

Nov 12, 2021

BUY
$5.31 - $8.25 $141,230 - $219,425
26,597 Added 3.13%
877,187 $5.11 Million
Q2 2021

Aug 12, 2021

SELL
$6.81 - $9.23 $24,795 - $33,606
-3,641 Reduced 0.43%
850,590 $6.86 Million
Q1 2021

May 13, 2021

BUY
$7.99 - $15.0 $4.71 Million - $8.85 Million
589,724 Added 222.95%
854,231 $7.11 Million
Q4 2020

Feb 09, 2021

SELL
$7.04 - $11.7 $1.74 Million - $2.89 Million
-246,947 Reduced 48.28%
264,507 $2.01 Million
Q3 2020

Nov 06, 2020

SELL
$9.98 - $18.04 $208,033 - $376,043
-20,845 Reduced 3.92%
511,454 $5.45 Million
Q2 2020

Aug 12, 2020

SELL
$7.49 - $15.16 $25,271 - $51,149
-3,374 Reduced 0.63%
532,299 $8.07 Million
Q1 2020

May 11, 2020

SELL
$4.62 - $18.74 $45,400 - $184,157
-9,827 Reduced 1.8%
535,673 $4.46 Million
Q4 2019

Feb 13, 2020

SELL
$14.6 - $18.13 $3.78 Million - $4.69 Million
-258,916 Reduced 32.19%
545,500 $9.22 Million
Q3 2019

Nov 12, 2019

BUY
$16.62 - $23.92 $799,754 - $1.15 Million
48,120 Added 6.36%
804,416 $14.9 Million
Q2 2019

Aug 13, 2019

BUY
$17.79 - $22.88 $1.1 Million - $1.41 Million
61,774 Added 8.89%
756,296 $17.3 Million
Q1 2019

May 14, 2019

BUY
$11.76 - $22.15 $645,118 - $1.22 Million
54,857 Added 8.58%
694,522 $14.6 Million
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $2.49 Million - $5.24 Million
-238,990 Reduced 27.2%
639,665 $7.36 Million
Q3 2018

Nov 13, 2018

BUY
$20.4 - $24.6 $4.76 Million - $5.74 Million
233,408 Added 36.17%
878,655 $20.2 Million
Q2 2018

Aug 13, 2018

BUY
$19.02 - $24.95 $272,043 - $356,859
14,303 Added 2.27%
645,247 $14.4 Million
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $8.77 Million - $11.6 Million
-388,819 Reduced 38.13%
630,944 $14.4 Million
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $1.3 Million - $2.17 Million
72,470 Added 7.65%
1,019,763 $26.7 Million
Q3 2017

Nov 13, 2017

BUY
$21.1 - $25.15 $20 Million - $23.8 Million
947,293
947,293 $21.3 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.